Krka Reports Fall in Nine-Month Profit

Novo Mesto, 17 November - Pharmaceutical group Krka posted a net profit of EUR 115.4m in the first nine months of 2011, which is 4% less than in the same period last year, while the core company's net profit dropped by 17.3% to EUR 109.2m. The company is planning to list its shares on the Warsaw Stock Exchange by end of June 2012.

Novo mesto The management of pharmaceutical company Krka presenting the nine-month results. Photo: Rasto Bozic/STA

Novo mesto
The management of pharmaceutical company Krka presenting the nine-month results.
Photo: Rasto Bozic/STA

Novo mesto The management of pharmaceutical company Krka presenting the nine-month results. Photo: Rasto Bozic/STA

Novo mesto
The management of pharmaceutical company Krka presenting the nine-month results.
Photo: Rasto Bozic/STA

Novo mesto Krka chairman Joze Colaric presenting the nine-month results of the pharmaceutical company. Photo: Rasto Bozic/STA

Novo mesto
Krka chairman Joze Colaric presenting the nine-month results of the pharmaceutical company.
Photo: Rasto Bozic/STA

The rest of this news item is available to subscribers.
The news item consists of 1.654 characters (without spaces) or 345 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

zm/ep/ep
© STA, 2011